Channel Therapeutics Stock Quote CHRO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.02

Bid

Ask

Volume

9,659

0.9241 Day's Range 1.04

0.45 52 Week Range 6.00

Market Cap

6.149M

Previous Close

0.9414

Open

0.93

Last Trade

0.9092

Last Trade Time

12:55:47

Financial Volume

$ 9,775

VWAP

1.012

Average Volume (3m)

116,257

Shares Outstanding

6,028,011

Dividend Yield

PE Ratio

-0.83

Earnings Per Share (EPS)

-1.22

Revenue

Net Profit

-7.38M

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

channeltherapeutics.com

Headquarters

Reno, Nevada, USA

Founded

Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was $0.94. Over the last year, Channel Therapeutics shares have traded in a share price range of $ 0.45 to $ 6.00.

Channel Therapeutics currently has 6,028,011 shares outstanding. The market capitalization of Channel Therapeutics is $5.67 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.83.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.09	9.67741935484	0.93	1.1	0.8103	98918	0.9628452	CS
4	0.345	51.1111111111	0.675	1.1	0.562	127637	0.71523888	CS
12	0.32	45.7142857143	0.7	1.1	0.45	116257	0.7155211	CS
26	-0.16	-13.5593220339	1.18	1.47	0.45	107201	0.7898318	CS
52	-4.98	-83	6	6	0.45	70410	1.04235794	CS
156	-4.98	-83	6	6	0.45	70410	1.04235794	CS
260	-4.98	-83	6	6	0.45	70410	1.04235794	CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?

The current share price of Channel Therapeutics is $ 1.02

How many Channel Therapeutics shares are in issue?

Channel Therapeutics has 6,028,011 shares in issue

What is the market cap of Channel Therapeutics?

The market capitalisation of Channel Therapeutics is USD 5.67M

What is the 1 year trading range for Channel Therapeutics share price?

Channel Therapeutics has traded in the range of $ 0.45 to $ 6.00 during the past year

What is the PE ratio of Channel Therapeutics?

The price to earnings ratio of Channel Therapeutics is -0.83

What is the reporting currency for Channel Therapeutics?

Channel Therapeutics reports financial results in USD

What is the latest annual profit for Channel Therapeutics?

The latest annual profit of Channel Therapeutics is USD -7.38M

What is the registered address of Channel Therapeutics?

The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501

What is the Channel Therapeutics website address?

The website address for Channel Therapeutics is channeltherapeutics.com

Which industry sector does Channel Therapeutics operate in?

Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UVIX2x Long VIX Futures ETF	$ 31.70 (780.56%)	2.94M
SATXSatixFy Communications Ltd	$ 1.54 (25.20%)	152.92k
MPUMega Matrix Inc	$ 1.37 (19.13%)	495.24k
ROLRHigh Roller Technologies Inc	$ 5.90 (17.30%)	51.54k
MITQMoving iMage Technologies Inc	$ 0.84 (16.65%)	81.17M
AZTRAzitra Inc	$ 0.252025 (-40.17%)	4.33M
TOVXTheriva Biologics Inc	$ 1.58 (-17.28%)	224.51k
MTNBMatinas Biopharma Holdings Inc	$ 0.5813 (-16.96%)	596.18k
BNDSInfrastructure Capital Bond Income ETF	50.30 (-12.99%)	7.21k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 2.1977 (-11.56%)	38.29M
MITQMoving iMage Technologies Inc	$ 0.84 (16.65%)	81.17M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	$ 6.1021 (-4.95%)	58.38M
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 30.09 (7.01%)	51.38M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 2.1977 (-11.56%)	38.29M
XLFFinancial Select Sector	$ 49.365 (2.31%)	36.45M